Karthik N. Rao, Veronica Fernandez-Alvarez, Orlando Guntinas-Lichius, M. P. Sreeram, Remco de Bree, Luiz P. Kowalski, Arlene Forastiere, Pia Pace-Asciak, Juan P. Rodrigo, Nabil F. Saba, Ohad Ronen, Ewa Florek, Gregory W. Randolph, Alvaro Sanabria, Jan B. Vermorken, Ehab Y. Hanna, Alfio Ferlito
{"title":"人工智能在头颈部肿瘤学中的局限性。","authors":"Karthik N. Rao, Veronica Fernandez-Alvarez, Orlando Guntinas-Lichius, M. P. Sreeram, Remco de Bree, Luiz P. Kowalski, Arlene Forastiere, Pia Pace-Asciak, Juan P. Rodrigo, Nabil F. Saba, Ohad Ronen, Ewa Florek, Gregory W. Randolph, Alvaro Sanabria, Jan B. Vermorken, Ehab Y. Hanna, Alfio Ferlito","doi":"10.1007/s12325-025-03198-4","DOIUrl":null,"url":null,"abstract":"<div><p>Artificial intelligence (AI) is revolutionizing head and neck oncology, offering innovations in tumor detection, treatment planning, and patient management. However, its integration into clinical practice is hindered by several limitations. These include clinician mistrust due to a lack of understanding of AI mechanisms, biases in algorithm development, and the potential over-reliance on technology, which may undermine clinical expertise. Data-related challenges, such as inconsistent quality and limited representativeness of datasets, further complicate AI’s application. Ethical, legal, and privacy concerns also pose significant barriers. Addressing these issues through transparent AI systems, clinician education, and clear regulations is essential for ensuring responsible, equitable use in head and neck oncology. This manuscript explores the limitations of AI in head and neck oncology.</p></div>","PeriodicalId":7482,"journal":{"name":"Advances in Therapy","volume":"42 6","pages":"2559 - 2568"},"PeriodicalIF":3.4000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12325-025-03198-4.pdf","citationCount":"0","resultStr":"{\"title\":\"The Limitations of Artificial Intelligence in Head and Neck Oncology\",\"authors\":\"Karthik N. Rao, Veronica Fernandez-Alvarez, Orlando Guntinas-Lichius, M. P. Sreeram, Remco de Bree, Luiz P. Kowalski, Arlene Forastiere, Pia Pace-Asciak, Juan P. Rodrigo, Nabil F. Saba, Ohad Ronen, Ewa Florek, Gregory W. Randolph, Alvaro Sanabria, Jan B. Vermorken, Ehab Y. Hanna, Alfio Ferlito\",\"doi\":\"10.1007/s12325-025-03198-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Artificial intelligence (AI) is revolutionizing head and neck oncology, offering innovations in tumor detection, treatment planning, and patient management. However, its integration into clinical practice is hindered by several limitations. These include clinician mistrust due to a lack of understanding of AI mechanisms, biases in algorithm development, and the potential over-reliance on technology, which may undermine clinical expertise. Data-related challenges, such as inconsistent quality and limited representativeness of datasets, further complicate AI’s application. Ethical, legal, and privacy concerns also pose significant barriers. Addressing these issues through transparent AI systems, clinician education, and clear regulations is essential for ensuring responsible, equitable use in head and neck oncology. This manuscript explores the limitations of AI in head and neck oncology.</p></div>\",\"PeriodicalId\":7482,\"journal\":{\"name\":\"Advances in Therapy\",\"volume\":\"42 6\",\"pages\":\"2559 - 2568\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s12325-025-03198-4.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12325-025-03198-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Therapy","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12325-025-03198-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
The Limitations of Artificial Intelligence in Head and Neck Oncology
Artificial intelligence (AI) is revolutionizing head and neck oncology, offering innovations in tumor detection, treatment planning, and patient management. However, its integration into clinical practice is hindered by several limitations. These include clinician mistrust due to a lack of understanding of AI mechanisms, biases in algorithm development, and the potential over-reliance on technology, which may undermine clinical expertise. Data-related challenges, such as inconsistent quality and limited representativeness of datasets, further complicate AI’s application. Ethical, legal, and privacy concerns also pose significant barriers. Addressing these issues through transparent AI systems, clinician education, and clear regulations is essential for ensuring responsible, equitable use in head and neck oncology. This manuscript explores the limitations of AI in head and neck oncology.
期刊介绍：
Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.
The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
